4//SEC Filing
WILSON TROY EDWARD 4
Accession 0001599901-25-000154
CIK 0001599901other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 5:42 PM ET
Size
21.7 KB
Accession
0001599901-25-000154
Insider Transaction Report
Form 4
WILSON TROY EDWARD
Director
Transactions
- Sale
Common Stock
2025-08-06$45.00/sh−22,000$990,000→ 69,425 total - Sale
Common Stock
2025-08-06$45.00/sh−15,000$675,000→ 285,000 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-08-06$12.48/sh+7,500$93,600→ 76,925 total - Sale
Common Stock
2025-08-06$45.00/sh−17,777$799,965→ 17,776 total(indirect: By Trust) - Sale
Common Stock
2025-08-06$45.00/sh−15,000$675,000→ 285,000 total(indirect: By Trust) - Sale
Common Stock
2025-08-06$45.00/sh−17,777$799,965→ 17,776 total(indirect: By Trust) - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-06−22,000→ 0 totalExercise: $12.03Exp: 2032-06-14→ Common Stock (22,000 underlying) - Exercise/Conversion
Common Stock
2025-08-06$12.03/sh+22,000$264,660→ 91,425 total - Sale
Common Stock
2025-08-06$45.00/sh−7,500$337,500→ 69,425 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-06−7,500→ 14,500 totalExercise: $12.48Exp: 2033-06-14→ Common Stock (7,500 underlying)
Holdings
- 13,711(indirect: By Trust)
Common Stock
- 11,851(indirect: By Trust)
Common Stock
- 11,851(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.
- [F2]All shares of common stock subject to this option were fully vested and exercisable as of the date of execution of this option by Reporting Person.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001589597
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 5:42 PM ET
- Size
- 21.7 KB